Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-17T20:10:49.502Z Has data issue: false hasContentIssue false
  • English
  • Français

Schizophrenia: A New Approach. II. Result of a Year's Research

Published online by Cambridge University Press:  08 February 2018

Abram Hoffer ,
Humphrey Osmond  and
John Smythies
Abram Hoffer
Affiliation:
Psychiatric Research in the Psychiatric Services Branch of the Department of Public Health, Saskatchewan
Humphrey Osmond
Affiliation:
Saskatchewan Hospital, Weyburn, Saskatchewan
John Smythies
Affiliation:
Saskatchewan Hospital, Weyburn, Saskatchwan
Get access Rights & Permissions [Opens in a new window]

Extract

About one year ago, with the encouragement of the Editor-in-Chief, a short paper appeared in this Journal entitled “Schizophrenia; A New Approach” (18). In this paper it was noted that mescaline and adrenaline have a similar biochemical structure. It was suggested that one of the aetiological agents in schizophrenia might be a substance or substances lying between these two; with the psychological properties of mescaline but effective in concentrations nearer those of adrenaline. Dr. Harley Mason elaborated this suggestion from the biochemical standpoint. For convenience these hypothetical substances were called, collectively, M substance. If M substance occurred in the body, it would account for the group of illnesses usually referred to as schizophrenia better than any hypothesis so far advanced. It has been the good fortune of the co-authors of that first paper (J. R. S. and H. O.) to be able to join forces with the third author of this paper (A. H.) to test the hypothsis. It is with the efforts of the last year that this paper is concerned.

Type
Part I.—Original Articles
Information
Journal of Mental Science , Volume 100 , Issue 418 , January 1954 , pp. 29 - 45
Copyright
Copyright © Royal College of Psychiatrists, 1954 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

List of References

1. Asouith, E., 1952. Private communication.Google Scholar
2. Bacq, Z. M., J. of Pharm. Exp. Ther., 1949, 95, 1.Google Scholar
3. Beyer, K. H., ibid., 1941, 71, 151.Google Scholar
4. Idem, Physiol. Rev., 1946, 26, 169.CrossRefGoogle Scholar
5. Blaschko, H., Nature, 1940, 145, 26.CrossRefGoogle Scholar
6. Bullough, W. S., The J. of Endocrinology, 1952, 8, 265.CrossRefGoogle Scholar
7. Burn, J. H., Brit. Med. J., 1952, i, 784.CrossRefGoogle Scholar
8. Eade, N., Hutcheon, D. E., 1952. Personal communication—to be published.Google Scholar
9. Fischer, R., Georgi, F., Weber, R., Piaget, R. H., Schweiz. Med. Wchnschr., 1950, 80, 129.Google Scholar
10. Green, D. E., Richter, D., Biochem. J., 1937, 31, 596.CrossRefGoogle Scholar
11. De Jong, H. H., Experimental Catatonia, 1945. Baltimore: The Williams & Wilkins Co.Google Scholar
12. Lettre, H., J. Clin. and Exp. Psychopath., 1951, 12, 241.Google Scholar
13. Lindemann, E., Am. J. Psychiat., 1935, 91, 983.CrossRefGoogle Scholar
14. Manske, R. H. F., Holmes, H. L., The Alkaloids, Vol. II, 1952. New York: Academic Press Inc.Google Scholar
15. Martin, G. J., Biological Antagonism, 1951. Toronto: The Blakeston Co., Inc.Google Scholar
16. Idem , Ichniowski, C. T., Wisansky, W. A., Ansbacher, S., Am. J. Physiol., 1942, 136, 66.Google Scholar
17. Meyerhof, O., Randall, L. O., Archiv. Biochem., 1948, 17, 171.Google Scholar
18. Osmond, H., Smythies, J., J. Ment. Sci., 1952, 98, 309.CrossRefGoogle Scholar
19. Szatmari, A., 1952. Personal communication—to be published.Google Scholar
20. Woodford, V., 1952. Private communication—to be published Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.